Downregulation of vascular endothelial growth factor and its receptors in the kidney in rats with puromycin aminonucleoside nephrosis

被引:25
作者
Fan, LY
Wakayama, T
Yokoyama, S
Amano, O
Iseki, S [1 ]
机构
[1] Kanazawa Univ, Dept Anat, Sch Med, Kanazawa, Ishikawa 9208640, Japan
[2] Kanazawa Univ, Dept Biophys Genet, Sch Med, Kanazawa, Ishikawa 9208640, Japan
来源
NEPHRON | 2002年 / 90卷 / 01期
关键词
puromycin aminonucleoside nephrosis; vascular endothelial growth factor; flt-1; flk-1; gene expression; Sprague-Dawley rat;
D O I
10.1159/000046320
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aim: We aimed to examine the possible involvement of vascular endothelial growth factor (VEGF) in the pathogenesis of puromycin aminonucleoside nephrosis (PAN). Methods: The expression and localization of the mRNA of VEGF and its receptors, flt-1 and flk-1, were analyzed in the kidneys of puromycin aminonucleoside-injected rats by use of Northern blotting and in situ hybridization. Results: In association with the induction of proteinuria, VEGF mRNA underwent decrease in amount from 3 days after the injection, reaching the minimum level at 7 days, followed by a gradual recovery by 28 days. The levels of flk-1 and flt-1 mRNA showed similar transient decrease in PAN kidney, whereas the mRNA of von Willebrand factor, a marker of endothelial cells, showed no change in amount. In the normal rat kidney, VEGF mRNA was localized primarily to podocytes, and flk-1 mRNA was localized exclusively to endothelial cells with much higher intensity in glomeruli than in peritubular capillaries. In PAN kidney, the intensities of both VEGF and flk-1 signals in podocytes and glomerular endothelial cells, respectively, appeared much lower at 7 days than in normal kidney. Conclusion: These results indicate that the VEGF-VEGF receptor system is down-regulated in PAN, implying that it is not involved in the mechanism of proteinuria in PAN. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:95 / 102
页数:8
相关论文
共 39 条
[1]  
ANDREWS PM, 1977, LAB INVEST, V36, P183
[2]   DIFFERENTIAL EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VASCULAR-PERMEABILITY FACTOR) FORMS IN RAT-TISSUES [J].
BACIC, M ;
EDWARDS, NA ;
MERRILL, MJ .
GROWTH FACTORS, 1995, 12 (01) :11-15
[3]  
BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141
[4]   VASCULAR-PERMEABILITY FACTOR MESSENGER-RNA AND PROTEIN EXPRESSION IN HUMAN KIDNEY [J].
BROWN, LF ;
BERSE, B ;
TOGNAZZI, K ;
MANSEAU, EJ ;
VANDEWATER, L ;
SENGER, DR ;
DVORAK, HF ;
ROSEN, S .
KIDNEY INTERNATIONAL, 1992, 42 (06) :1457-1461
[5]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[6]   AMINO-ACID AND CDNA SEQUENCES OF A VASCULAR ENDOTHELIAL-CELL MITOGEN THAT IS HOMOLOGOUS TO PLATELET-DERIVED GROWTH-FACTOR [J].
CONN, G ;
BAYNE, ML ;
SODERMAN, DD ;
KWOK, PW ;
SULLIVAN, KA ;
PALISI, TM ;
HOPE, DA ;
THOMAS, KA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (07) :2628-2632
[7]   Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes [J].
Cooper, ME ;
Vranes, D ;
Youssef, S ;
Stacker, SA ;
Cox, AJ ;
Rizkalla, B ;
Casley, DJ ;
Bach, LA ;
Kelly, DJ ;
Gilbert, RE .
DIABETES, 1999, 48 (11) :2229-2239
[8]   THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
DEVRIES, C ;
ESCOBEDO, JA ;
UENO, H ;
HOUCK, K ;
FERRARA, N ;
WILLIAMS, LT .
SCIENCE, 1992, 255 (5047) :989-991
[9]  
DVORAK HF, 1995, AM J PATHOL, V146, P1029
[10]   Immunohistochemical localization of vascular endothelial growth factor in the globule leukocyte mucosal mast cell of the rat respiratory and digestive tracts [J].
Fan, LY ;
Iseki, S .
HISTOCHEMISTRY AND CELL BIOLOGY, 1999, 111 (01) :13-21